通过基于绩效的支付整合病例管理应对结核病依从性挑战:格鲁吉亚整群随机对照试验方案
本方案介绍一项两臂整群随机对照试验,在格鲁吉亚结核病管理表现不佳的卫生机构中,评估基于绩效 financing 与整合照护干预对结核病失访和治疗依从性的效果。干预机构卫生人员组成病例管理团队并接受整合结核病照护培训,依据患者依从治疗月记录和照护质量评估发放绩效相关报酬。主要结局为成人药物敏感和耐药肺结核患者的失访,检测药物敏感患者失访降低6%和耐药患者失访降低20%所需样本量分别为948例和136例。
要点
- 两臂整群随机对照试验,在格鲁吉亚结核病管理表现不佳的卫生机构开展。
- 干预为卫生人员组成病例管理团队、接受整合结核病照护培训并接受绩效相关支付。
- 主要结局为成人药物敏感和耐药肺结核患者的失访。
核心结论
- 该试验旨在为基于供方绩效 financing 与整合照护干预对结核病失访和治疗依从性的效果提供严格证据,并配套开展现实主义评估和卫生经济学评估。
研究设计与样本
- 两臂整群随机对照试验,在格鲁吉亚结核病管理表现不佳的卫生机构(集群)中开展;符合条件并同意的机构随机分配至干预组或对照组(标准照护)。
- 干预机构卫生人员组成病例管理团队并接受整合结核病照护培训,依据患者依从治疗月记录和照护质量评估向卫生人员发放绩效相关报酬。
- 检测药物敏感结核病患者失访降低6%所需样本量为948例患者,检测耐药结核病患者失访降低20%所需样本量为136例患者。
- 试验注册号ISRCTN14667607,注册日期2019年1月14日。
主要发现
- 主要结局包括成人药物敏感和耐药肺结核患者的失访。
- 次要结局包括药物敏感和耐药结核病患者的治疗依从性,以及药物敏感结核病患者的治疗成功。
- 还将收集社会人口学特征、结核病诊断和治疗方案数据。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tuberculosis is one of the greatest global health concerns and disease management is challenging particularly in low- and middle-income countries. Despite improvements in addressing this epidemic in Georgia, tuberculosis remains a significant public health concern due to sub-optimal patient management. Low remuneration for specialists, limited private-sector interest in provision of infectious disease care and incomplete integration in primary care are at the core of this problem. METHODS: This protocol sets out the methods of a two-arm cluster randomized control trial which aims to generate evidence on the effectiveness of a performance-based financing and integrated care intervention on tuberculosis loss to follow-up and treatment adherence. The trial will be implemented in health facilities (clusters) under-performing in tuberculosis management. Eligible and consenting facilities will be randomly assigned to either intervention or control (standard care). Health providers within intervention sites will form a case management team and be trained in the delivery of integrated tuberculosis care; performance-related payments based on monthly records of patients adhering to treatment and quality of care assessments will be disbursed to health providers in these facilities. The primary outcomes include loss to follow-up among adult pulmonary drug-sensitive and drug-resistant tuberculosis patients. Secondary outcomes are adherence to treatment among drug-sensitive and drug-resistant tuberculosis patients and treatment success among drug-sensitive tuberculosis patients. Data on socio-demographic characteristics, tuberculosis diagnosis and treatment regimen will also be collected. The required sample size to detect a 6% reduction in loss to follow-up among drug-sensitive tuberculosis patients and a 20% reduction in loss to follow-up among drug-resistant tuberculosis patients is 948 and 136 patients, respectively. DISCUSSION: The trial contributes to a limited body of rigorous evidence and literature on the effectiveness of supply-side performance-based financing interventions on tuberculosis patient outcomes. Realist and health economic evaluations will be conducted in parallel with the trial, and associated composite findings will serve as a resource for the Georgian and wider regional Ministries of Health in relation to future tuberculosis and wider health policies. The trial and complementing evaluations are part of Results4TB, a multidisciplinary collaboration engaging researchers and Georgian policy and practice stakeholders in the design and evaluation of a context-sensitive tuberculosis management intervention. TRIAL REGISTRATION: ISRCTN, ISRCTN14667607 . Registered on 14 January 2019.
引用
- Chikovani I, Diaconu K, Duric P, et al. Addressing challenges in tuberculosis adherence via performance-based payments for integrated case management: protocol for a cluster randomized controlled trial in Georgia. Trials. 2019. PMID: 31462284. doi:10.1186/s13063-019-3621-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。